Financials
- Market Capitalization 398.74 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3069 | GALT Galectin Therapeutics Inc. - Common Stock | 4.02 USD | -2.90% | +9.24% | +23.31% | -6.07% | 405.42 M USD | ||
| 3076 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | -4.49% | +0.25% | +1.00% | +36.03% | 400.55 M USD | ||
| 3085 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.60 USD | -1.45% | +1.19% | +4.78% | +56.32% | 396.11 M USD | ||
| 3090 | CTNM Contineum Therapeutics, Inc. - Common stock | 17.05 USD | -1.16% | +0.29% | +8.25% | +11.66% | 393.84 M USD |